These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19090921)

  • 1. Potential glucocorticoid receptor ligands with pulmonary selectivity using I-QSAR with the signature molecular descriptor.
    Jackson JD; Weis DC; Visco DP
    Chem Biol Drug Des; 2008 Dec; 72(6):540-50. PubMed ID: 19090921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR study of selective ligands for the thyroid hormone receptor beta.
    Liu H; Gramatica P
    Bioorg Med Chem; 2007 Aug; 15(15):5251-61. PubMed ID: 17524652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor binding: a biphasic dependence on molecular size as revealed by the bilinear LinBiExp model.
    Buchwald P
    Steroids; 2008 Feb; 73(2):193-208. PubMed ID: 18022656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor.
    Xu Y; Zhang T; Chen M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):393-6. PubMed ID: 19081253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular complexity analysis of de novo designed ligands.
    Boda K; Johnson AP
    J Med Chem; 2006 Oct; 49(20):5869-79. PubMed ID: 17004702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling of globulin binding affinity of corticosteroids using AM1 calculations.
    De K; Sengupta C; Roy K
    Bioorg Med Chem; 2004 Jun; 12(12):3323-32. PubMed ID: 15158800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators.
    Onnis V; Kinsella GK; Carta G; Jagoe WN; Price T; Williams DC; Fayne D; Lloyd DG
    J Med Chem; 2010 Apr; 53(8):3065-74. PubMed ID: 20334371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
    Stiefl N; Baumann K
    J Med Chem; 2003 Apr; 46(8):1390-407. PubMed ID: 12672239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based approach for the study of estrogen receptor binding affinity and subtype selectivity.
    Salum LB; Polikarpov I; Andricopulo AD
    J Chem Inf Model; 2008 Nov; 48(11):2243-53. PubMed ID: 18937440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge-based design of target-focused libraries using protein-ligand interaction constraints.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2006 Jan; 49(2):490-500. PubMed ID: 16420036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of the interaction specificity between the human glucocorticoid receptor and its endogenous steroid ligand cortisol.
    von Langen J; Fritzemeier KH; Diekmann S; Hillisch A
    Chembiochem; 2005 Jun; 6(6):1110-8. PubMed ID: 15883974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K; Filipic S; Agbaba D
    Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease.
    Uings IJ; Farrow SN
    Curr Opin Pharmacol; 2005 Jun; 5(3):221-6. PubMed ID: 15907906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
    Vijayan RS; Ghoshal N
    J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α.
    Onnis V; Kinsella GK; Carta G; Fayne D; Lloyd DG
    Future Med Chem; 2009 Jun; 1(3):483-99. PubMed ID: 21426128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
    Xia B; Ma W; Zheng B; Zhang X; Fan B
    Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.
    Jyrkkärinne J; Windshügel B; Rönkkö T; Tervo AJ; Küblbeck J; Lahtela-Kakkonen M; Sippl W; Poso A; Honkakoski P
    J Med Chem; 2008 Nov; 51(22):7181-92. PubMed ID: 18983136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
    McMaster A; Ray DW
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.